CG
NAUT icon

Caprock Group’s Nautilus Biotechnolgy NAUT Stock Holding History

Caprock Group’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.1K Buy
47,090
+3,000
+7% +$7.92K ﹤0.01% 1209
2026
Q1 		$171K Hold
44,090
– – ﹤0.01% 1060
2025
Q4 		$86K Buy
44,090
+27,000
+158% +$44.3K ﹤0.01% 1162
2025
Q3 		$11.6K Buy
+17,090
New +$12.6K ﹤0.01% 1121
2025
Q1 		$8.69K Buy
+10,090
New +$15K ﹤0.01% 1074
2022
Q2 		– Sell
-24,790
Closed -$108K – 607
2022
Q1 		$108K Buy
+24,790
New +$102K 0.01% 590

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Caprock Group's NAUT Position: Q2 2026 in Review

Caprock Group increased its Nautilus Biotechnolgy (NAUT) stake by 6.8% in Q2 2026, buying an estimated $7.92K and bringing the position to 47,090 shares worth $88.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1209.

Caprock Group first reported a position in NAUT in Q1 2022 and has held it in 6 quarters since. The position peaked at $171K in Q1 2026. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Caprock Group held 47,090 shares of Nautilus Biotechnolgy worth $88.1K as of Q2 2026.
  • Caprock Group bought 3,000 Nautilus Biotechnolgy shares in Q2 2026, an estimated $7.92K.
  • Nautilus Biotechnolgy made up ﹤0.01% of Caprock Group's portfolio in Q2 2026, its #1209 holding.
  • Caprock Group first reported a position in Nautilus Biotechnolgy in Q1 2022 and has held it in 6 quarters since.
  • Caprock Group's Nautilus Biotechnolgy position peaked at $171K in Q1 2026.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.